US Stock MarketDetailed Quotes

MTNB Matinas BioPharma

Watchlist
  • 0.1577
  • -0.0216-12.05%
Close Jul 22 16:00 ET
  • 0.1634
  • +0.0057+3.61%
Post 18:01 ET
39.55MMarket Cap-1433P/E (TTM)

Matinas BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Matinas BioPharma Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 9, 2024

Revenue(YoY)

0.00

-100.00%
EPS(YoY)

-0.03

0.00%
Analyst Rating

Buy

Jun 30, 2024

Matinas BioPharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 9, 20242024/Q10.000 / 0.000--
Mar 27, 20242023/Q40.000 / 0.000--
Nov 8, 20232023/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 0.000--
--2024/Q2-- / 0.000--
May 9, 20242024/Q10.000 / 0.000--
Mar 27, 20242023/Q40.000 / 0.000--
Nov 8, 20232023/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Matinas BioPharma Earnings Reports

  • Matinas BioPharma | 10-Q: Quarterly report

    May 9 16:04 ET

  • Matinas BioPharma | 10-K: Annual report

    Mar 27 16:06 ET

  • Matinas BioPharma: Q3 2023 Earnings Report

    Nov 8, 2023 16:01 ET

  • Matinas BioPharma | 10-Q: Q2 2023 Earnings Report

    Aug 9, 2023 16:02 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jun 30, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg